What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials.
Kathryn KingSerena McGuinnessNatalie WatsonChristine NortonTrudie ChalderWladyslawa Czuber-DochanPublished in: Patient preference and adherence (2023)
Tailored, face-to-face, 1:1 interactions with healthcare professionals were successful at providing personalised adherence support. Accessible, user-friendly technology-based tools supported by calendars and reminders effectively enhanced adherence. Key components of effective interventions should be evaluated and integrated further into clinical practice if viable, whilst being tailored to inflammatory conditions.
Keyphrases
- multiple sclerosis
- rheumatoid arthritis
- clinical practice
- physical activity
- smoking cessation
- oxidative stress
- disease activity
- glycemic control
- white matter
- type diabetes
- systemic lupus erythematosus
- ankylosing spondylitis
- interstitial lung disease
- adipose tissue
- low cost
- systemic sclerosis
- insulin resistance
- idiopathic pulmonary fibrosis